×
0.014354066985646 0.014354066985646 0.014354066985646 0.014354066985646 0.0334736842105265 0.0334736842105265 0.0159234449760767 0.00478468899521538
Stockreport

KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug

KEMPHARM (KMPH)  More Company Research Source: GlobeNewswire
Last kempharm earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.kempharm.com/investor-overview
PDF Highlights of KP415.A01 Oral HAP Trial Results: Oral Human Abuse Potential Trial with KP415 Prodrug (KP415.A01) Clinical Findings Mean Drug Liking (Emax) of KP415 Prodrug (serdexmethylphenidate) at both 120 mg and 240 mg doses were statistically significantly lower than Focalin® XR at 80 mg Mean Drug Liking (Emax) of KP415 Prodrug at 120 mg dose was statistically significantly lower than 60 mg of phentermine, a schedule IV controlled substance CORALVILLE, Iowa, Sept. 11, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced topline results from its oral human abuse potential (HAP) clinical trial of serdexmethylphenidate (SDX, a prodrug of d-methylphenidate, or KP415 Prodrug), [Read more]

IMPACT SNAPSHOT EVENT TIME: KMPH
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
KMPH alerts
from News Quantified
Opt-in for
KMPH alerts

from News Quantified
Opt-in for
KMPH alerts

from News Quantified